Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2005 3
2006 1
2007 3
2008 4
2009 4
2010 6
2011 4
2012 1
2014 4
2015 2
2016 1
2017 1
2018 4
2019 2
2020 2
2021 3
2022 3
2023 3

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
Khan P, Siddiqui JA, Kshirsagar PG, Venkata RC, Maurya SK, Mirzapoiazova T, Perumal N, Chaudhary S, Kanchan RK, Fatima M, Khan MA, Rehman AU, Lakshmanan I, Mahapatra S, Talmon GA, Kulkarni P, Ganti AK, Jain M, Salgia R, Batra SK, Nasser MW. Khan P, et al. Among authors: mirzapoiazova t. Mol Cancer. 2023 Jan 4;22(1):1. doi: 10.1186/s12943-022-01695-6. Mol Cancer. 2023. PMID: 36597126 Free PMC article.
Targeting the mercapturic acid pathway for the treatment of melanoma.
Singhal SS, Srivastava S, Mirzapoiazova T, Horne D, Awasthi S, Salgia R. Singhal SS, et al. Among authors: mirzapoiazova t. Cancer Lett. 2021 Oct 10;518:10-22. doi: 10.1016/j.canlet.2021.06.004. Epub 2021 Jun 11. Cancer Lett. 2021. PMID: 34126193 Review.
Addressing Drug Resistance in Cancer: A Team Medicine Approach.
Kulkarni P, Mohanty A, Bhattacharya S, Singhal S, Guo L, Ramisetty S, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Gupta N, Kim P, Babikian R, Rajurkar S, Subbiah S, Tan T, Nguyen D, Merla A, Kollimuttathuillam SV, Phillips T, Baik P, Tan B, Vashi P, Shrestha S, Leach B, Garg R, Rich PL, Stewart FM, Pisick E, Salgia R. Kulkarni P, et al. Among authors: mirzapoiazova t. J Clin Med. 2022 Sep 27;11(19):5701. doi: 10.3390/jcm11195701. J Clin Med. 2022. PMID: 36233569 Free PMC article.
Correction: Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Arvanitis LD, Atri P, Muschen M, Tissot FLH, Miser J, Kovach JS, Sattler M, Batra SK, Kulkarni P, Salgia R. Mirzapoiazova T, et al. Mol Cancer Ther. 2022 Apr 1;21(4):700. doi: 10.1158/1535-7163.MCT-22-0104. Mol Cancer Ther. 2022. PMID: 35373301 No abstract available.
Co-stimulatory and co-inhibitory immune markers in solid tumors with MET alterations.
Reckamp KL, McQuerry JA, Mambetsariev I, Pharaon R, Yost SE, Fricke J, Mirzapoiazova T, Pillai RK, Khan Z, Fakih M, Yuan Y, Koczywas M, Massarelli E, Kulkarni P, Pal SK, Sattler M, Bild A, Salgia R. Reckamp KL, et al. Among authors: mirzapoiazova t. Future Sci OA. 2020 Nov 25;7(2):FSO662. doi: 10.2144/fsoa-2020-0159. Future Sci OA. 2020. PMID: 33437521 Free PMC article.
Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Zhao D, Li H, Mambetsariev I, Mirzapoiazova T, Chen C, Fricke J, Kulkarni P, Villaflor V, Arvanitis L, Hamilton S, Afkhami M, Pillai R, Armstrong B, Erhunmwunsee L, Massarelli E, Sattler M, Amini A, Salgia R. Zhao D, et al. Among authors: mirzapoiazova t. Cancers (Basel). 2022 Oct 8;14(19):4933. doi: 10.3390/cancers14194933. Cancers (Basel). 2022. PMID: 36230855 Free PMC article.
Protein Phosphatase 2A as a Therapeutic Target in Small Cell Lung Cancer.
Mirzapoiazova T, Xiao G, Mambetsariev B, Nasser MW, Miaou E, Singhal SS, Srivastava S, Mambetsariev I, Nelson MS, Nam A, Behal A, Arvanitis LD, Atri P, Muschen M, Tissot FLH, Miser J, Kovach JS, Sattler M, Batra SK, Kulkarni P, Salgia R. Mirzapoiazova T, et al. Mol Cancer Ther. 2021 Oct;20(10):1820-1835. doi: 10.1158/1535-7163.MCT-21-0013. Epub 2021 Jul 12. Mol Cancer Ther. 2021. PMID: 34253596 Free PMC article.
A Systems Biology Approach for Addressing Cisplatin Resistance in Non-Small Cell Lung Cancer.
Ramisetty S, Kulkarni P, Bhattacharya S, Nam A, Singhal SS, Guo L, Mirzapoiazova T, Mambetsariev B, Mittan S, Malhotra J, Pisick E, Subbiah S, Rajurkar S, Massarelli E, Salgia R, Mohanty A. Ramisetty S, et al. Among authors: mirzapoiazova t. J Clin Med. 2023 Jan 11;12(2):599. doi: 10.3390/jcm12020599. J Clin Med. 2023. PMID: 36675528 Free PMC article.
47 results